RETRACTABLE TECHNOLOGIES, INC. DECLARES DIVIDENDS TO SERIES I AND II CLASS B

TECHNOLOGIES, INC. DECLARES DIVIDENDS TO SERIES I AND II CLASS B SHAREHOLDERS

LITTLE ELM, Texas, March 28, 2007 Retractable Technologies, Inc. (AMEX:

RVP) announced today that its board of directors has declared dividends to

holders of Series I Class B and Series II Class B Convertible Preferred Stock

in the amount of $270,000 and $790,000, respectively. Dividends have accrued at 10% per annum and

cover amounts in arrears from July 1, 2004 through date of conversion or June

30, 2007, whichever is applicable. The

dividends will be paid on July 24, 2007 to shareholders of record as of the

close of business on July 2, 2007.

Technologies, Inc. manufactures and markets VanishPoint automated retraction

safety syringes and blood collection devices, which virtually eliminate health

care worker exposure to accidental needlestick injuries. These revolutionary

devices use a patented friction ring mechanism that causes the contaminated

needle to retract automatically from the patient into the barrel of the device,

a feature that is designed to prevent reuse. VanishPoint safety needle devices

are distributed by various specialty and general line distributors. For more

information on Retractable, visit our Web site at www.vanishpoint.com.

statements in this press release are made pursuant to the safe harbor provision

of the Private Securities Litigation Reform Act of 1995 and reflect the Company s

current views with respect to future events. The Company believes that the

expectations reflected in such forward-looking statements are accurate.

However, the Company cannot assure you that such expectations will materialize.

The Company s actual future performance could differ materially from such

cause or contribute to such differences include, but are not limited to: the

impact of dramatic increases in demand; the Company s ability to maintain and

quickly increase its production capacity in the event of a dramatic increase in

demand; the Company s ability to access the market; the Company s ability to

decrease production costs; the Company s ability to continue to finance

research and development as well as operations and expansion of production; the

increased interest of other larger market players, specifically Becton

Dickinson and Company, Inc., in providing safety needle devices to their

customers; and other risks and uncertainties that are detailed from time to

time in the Company s periodic reports filed with the Securities and Exchange

Vice President and Chief Financial Officer

(888) 806-2626 or (972) 294-1010

Communications Director

(212) 490-0811 or (214) 912-7415 (cell)